Skip to content

Imaging Radiotherapy-induced brain injury using advanced MRI and PET, a pilot

Imaging Radiotherapy-induced brain injury using advanced MRI and PET, a pilot - Imaging Radiotherapy-induced brain injury using MRI and PET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54488
Enrollment
40
Registered
2021-09-16
Start date
2022-01-27
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain injury after radiotherapy

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - adults (>18 years), - referred for treatment of tumours located in nasopharynx, parotids, oropharynx, skull base and sinonasal cavity (under which meningioma, pituitary, chondrosarcoma, chondroma) with radiotherapy (photons or protons), with or without systemic treatment, with a close proximity of 2 cm of the clinical target volume (CTV elective dose) to the brain or brainstem.

Exclusion criteria

Exclusion criteria: - age

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: The occurrence, location and appearance of brain microvascular and white matter radiotherapy-induced changes on sequentially obtained MRI & PET images performed in several time points in comparison with the baseline MRI and PET images and conventional MRI images.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)